Prime Medicine, Inc. logo PRME - Prime Medicine, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 7
HOLD 3
SELL 0
STRONG
SELL
0
| PRICE TARGET: $7.50 DETAILS
HIGH: $9.00
LOW: $6.00
MEDIAN: $7.50
CONSENSUS: $7.50
UPSIDE: 107.76%
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2019 Q4
Revenue
Revenue 1.2 0.9 0.8 1.2 1.1 1.5 2.2 0.2 0 0.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue 0 1.9 0 44.0 1.9 0 0 0 0 1.3 0 0 0 0 0 0 0 0 0 0 1.2 4.6 1.3 0
Gross Profit 1.2 (1) 0.8 (42.8) (0.7) 1.5 2.2 0.2 0 (0.7) 0 0 0 0 0 0 0 0 0 0 (1.2) (4.6) (1.3) 0
Operating Expenses
R&D Expenses 33.4 34.1 34.7 44.0 41.4 40.6 34.1 40.3 43.1 37.8 41.5 41.0 34.6 30.9 29.1 25.0 18.9 13.7 52.9 7.4 5.7 4.6 1.3 0.9
SG&A Expenses 11.0 17.4 14.7 11.2 13.1 13.3 12.3 14.1 12.6 11.2 13.1 10.5 10.7 9.2 9.6 6.6 7.4 6.2 7.2 3.0 1.2 1.4 1.3 1.3
Other Expenses 0 (1.9) 0 (44.0) (1.9) 0 0 0 0 (1.3) 13.5 (0.0) 0 0 0 0 0 0 0 0 0 (4.6) (1.3) 0
Operating Expenses 44.4 49.7 49.4 11.2 52.6 53.8 46.4 54.4 55.7 47.6 68.0 51.5 45.3 40.0 38.7 31.7 26.3 19.9 60.1 10.4 6.9 1.4 1.3 2.2
Operating Income
Operating Income (43.3) (50.7) (48.6) (54.0) (53.4) (52.4) (44.2) (54.2) (55.7) (48.3) (68.0) (51.5) (45.3) (40.0) (38.7) (31.7) (26.3) (19.9) (60.1) (10.4) (8.0) (6.0) (2.6) (2.2)
Interest Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest Income 0.8 1.5 1.1 1.1 1.3 1.2 1.5 0.7 0.6 0.7 0 0.4 0.6 0 0 0 0 0 0 0 0 0 0 0
Profitability
EBITDA (40.3) (47.3) (44.2) (48.7) (50.7) (50.2) (40.6) (51.0) (53.9) (44.3) (53.3) (50.2) (41.2) (38.5) (38.6) (28.5) (29.4) (24.1) (61.3) (18.6) 2.9 (5.9) (2.6) (2.2)
EBIT (42.1) (49.1) (46.1) (50.6) (52.6) (51.9) (42.3) (52.5) (55.5) (45.6) (54.5) (51.5) (42.4) (39.6) (39.5) (29.1) (29.8) (24.4) (61.5) (18.8) 1.7 (6.0) (2.6) (2.2)
Income Before Tax (42.1) (49.1) (46.1) (50.6) (52.6) (51.9) (42.3) (52.5) (55.5) (45.6) (65.6) (50.8) (42.4) (39.6) (39.5) (29.1) (29.8) (24.4) (61.5) (18.8) 1.7 (87.3) (0.7) (2.5)
Income Tax Expense 0 0 0 0 0 0 0 0 (0.1) 0.1 0 (0.1) 0.0 (0.2) (0.2) 0.2 (0.4) (0.5) 1.4 (2.4) 1.1 (0.6) 1.9 0.0
Net Income (42.1) (49.1) (46.1) (50.6) (52.6) (51.9) (42.3) (52.5) (55.3) (45.8) (65.6) (50.7) (42.4) (39.4) (39.3) (35.7) (29.3) (23.8) (62.9) (16.4) 0.6 (86.7) (2.6) (2.5)
Per Share Data
EPS (Basic) -0.24 -0.28 -0.26 -0.32 -0.41 -0.40 -0.36 -0.44 -0.46 -0.44 -0.67 -0.55 -0.47 -0.44 -0.42 -0.37 -0.37 -0.31 -0.72 -0.24 -0.04 -0.92 -0.04 -0.03
EPS (Diluted) -0.24 -0.28 -0.26 -0.32 -0.41 -0.40 -0.36 -0.44 -0.46 -0.44 -0.67 -0.55 -0.47 -0.44 -0.42 -0.37 -0.37 -0.31 -0.72 -0.24 -0.04 -0.92 -0.04 -0.03
Shares Outstanding 177.2 177.1 148.8 160.5 129.2 130.9 118.6 119.8 119.2 104.5 97.4 91.8 90.5 89.1 97.2 97.2 95.7 95.7 95.7 95.7 95.7 95.7 95.7 95.7
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3
Current Assets
Cash & Cash Equivalents 47.5 64.1 63.0 71.4 53.8 91.9 182.5 118.0 55.6 94.2 41.6 44.0 120.6 133.5 187.6 47.9 92.2 164.2 185.4 200.7
Short-Term Investments 47.6 71.4 114.6 137.0 47.9 52.4 8.0 57.5 107.3 116.6 80.1 121.4 87.0 116.1 106.3 98.7 88.4 47.0 84.2 99.3
Net Receivables 0 0 0 0 0.1 0.0 0 55 0 0 0 0 0 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 1.7 2.4 3.6 23.0 19.4 16.5 14.7 9.5 3.7 2.7 2.3 19.2 10.9 4.0 0.2 0 0 0 0 0
Total Current Assets 96.8 137.9 181.3 231.4 121.3 163.8 211.9 246.1 170.8 217.7 143.0 184.5 218.5 253.5 296.6 148.8 181.6 212.0 270.6 300.4
Non-Current Assets
Property, Plant & Equipment 137.5 142.2 146.7 139.9 144.0 150.3 71.6 72.7 75.4 79.5 36.6 39.3 47.1 48.3 48.6 47.3 47.6 15.7 15.7 14.0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 0 0 13.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 14.7 14.7 14.7 13.7 0 14.1 14.1 14.1 13.5 14.3 14.3 15.3 15.3 15.1 15.1 19.1 18.4 16.9 15.6 0.8
Total Non-Current Assets 152.2 156.8 161.4 153.6 157.7 164.4 85.6 86.7 88.9 93.7 50.9 54.6 62.4 63.4 63.7 66.4 66.0 32.6 31.3 14.8
Total Assets 249.0 294.7 342.7 385.0 279.0 328.2 297.5 332.8 259.7 311.4 193.9 239.1 280.9 316.9 360.3 215.3 247.6 244.6 301.9 315.2
Current Liabilities
Account Payables 5.8 12.3 8.9 9.4 6.4 10.0 11.4 5.4 4.6 10.1 19.5 14.1 5.5 4.6 4.3 4.1 5.9 3.2 1.4 1.4
Short-Term Debt 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Revenue 7.9 7.3 7.8 7.0 8.3 8.2 7.1 9.3 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 9.0 4.3 9.0 8.8 6.9 6.9 10.2 8.6 6.0 4.0 9.9 6.5 5.3 2.3 7.0 4.3 2.8 1.1 14.7 0.0
Total Current Liabilities 31.7 36.3 37.4 35.0 34.1 34.3 38.0 37.9 20.7 24.4 56.4 39.4 28.7 23.9 26.7 22.2 23.8 12.9 58.0 9.5
Non-Current Liabilities
Long-Term Debt 0 106.0 108.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0.1 0 0 0.1 0.1 0.3 0.5 0.3 0 1.2 0
Other Non-Current Liabilities 18 75.8 76.1 18 71.6 0 6 0 0 0 0 0 0 0 0 0 0 0.7 0 0
Total Non-Current Liabilities 177.5 181.7 184.4 188.2 184.0 187.0 106.4 105.4 42.4 43.2 4.4 5.8 12.0 14.3 17.3 20.3 23.0 2.8 4.3 4.3
Total Liabilities 209.2 218.0 221.9 223.2 218.1 221.2 144.4 143.3 63.1 67.6 60.8 45.2 40.8 38.1 44.0 42.6 46.9 15.7 62.3 13.8
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0.0 0.0 0.0 0.0
Retained Earnings (979.6) (937.5) (888.4) (842.3) (791.7) (739.1) (687.2) (644.9) (592.4) (537.1) (491.3) (425.7) (375.0) (332.6) (293.2) (253.9) (224.6) (195.2) (171.4) (108.5)
Accumulated Other Comprehensive Income (0.0) (0.0) 0.1 0.0 (0.0) (0.0) 0.0 0.0 (0.1) (0.1) (0.0) (0.1) (0.3) (0.2) (0.4) (0.5) (0.1) (0.0) (0.0) (0.0)
Total Stockholders' Equity 39.8 76.7 120.9 161.8 60.9 106.9 153.1 189.5 196.6 243.8 133.1 194.0 240.1 278.8 316.3 172.7 200.7 228.9 239.6 301.4
Total Liabilities & Equity 249.0 294.7 342.7 385.0 279.0 328.2 297.5 332.8 259.7 311.4 193.9 239.1 280.9 316.9 360.3 215.3 247.6 244.6 301.9 315.2
Debt Metrics
Total Debt 112.5 114.5 116.4 118.1 119.7 121.2 40.8 41.2 41.6 43.8 13.6 17.0 25.4 26.0 28.7 31.4 34.7 8.1 10.4 9.7
Net Debt 65.0 50.4 53.4 46.7 65.9 29.3 (141.7) (76.7) (14.0) (50.4) (27.9) (26.9) (95.1) (107.5) (158.9) (16.5) (57.5) (156.2) (175.0) (190.9)
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2019 Q4
Operating Activities
Net Income (42.1) (49.1) (46.1) (50.6) (52.6) (51.9) (42.3) (52.5) (55.3) (45.8) (65.6) (50.7) (42.4) (39.4) (39.3) (29.4) (29.3) (23.8) (62.9) (16.4) 0.6 (86.7) (2.6) (2.5)
Depreciation & Amortization 1.8 1.9 0.5 1.9 1.5 1.5 1.7 1.6 1.5 1.3 1.2 1.2 1.1 1.1 0.9 0.6 0.4 0.3 0.2 0.2 1.2 0.7 0.0 0
Stock-Based Compensation 4.9 4.6 4.5 12.7 6.3 5.7 5.9 6.8 8.1 5.2 4.4 4.2 3.6 1.7 2.6 1.4 1.3 1.1 1.1 0.3 0 0 (0.3) 0.2
Change in Working Capital (8.1) (2.5) 1.2 0.6 0.5 (7.7) 48.9 3.6 8.8 (30.1) 14.4 2.4 (5.6) (8.6) 1.2 (3.8) 1.6 (34.3) 31.6 (0.8) 0.2 0.2 0.5 0.5
Other Non-Cash Items 2.6 2.4 2.6 0.3 2.9 3.5 2.0 14.6 (8.4) 1.5 6.3 3.8 2.4 3.9 4.2 0.8 6.2 6.5 15.6 9.4 (9.5) 81.5 (0.2) 0.5
Operating Cash Flow (41.0) (42.7) (37.3) (35.0) (41.4) (48.9) 16.2 (25.9) (45.5) (67.7) (43.9) (39.2) (40.8) (41.6) (30.7) (30.1) (20.2) (50.8) (13.2) (9.6) (6.4) (4.9) (2.5) (1.3)
Investing Activities
Capital Expenditure (0.0) (0.2) (0.3) (0.2) (1.6) (2.4) (1.8) (1.3) (1.9) (2.3) (1.8) (2.9) (2.0) (2.0) (4.8) (4.8) (4.8) (1.7) (0.4) (1.8) (0.9) (1.0) (0.3) 0
Acquisitions 0 0 0 0 0 0 0 0 0 0 (0.0) 0.0 0 0 0 0.0 0 0 0 0 0 0 0 0
Purchases of Investments (19.0) (7.3) (15.9) (134.3) (6.9) (48.3) 16.9 (10.4) (28.7) (107.2) (4.4) (54.9) 0.0 (45.7) (33.9) (14.7) (74.7) 0 (0.1) (5.9) (75.9) 0 0 0
Sales/Maturities of Investments 43.1 50.9 44.5 42.4 11.2 3 32.9 61.3 37.5 72.5 47.5 20.0 30 35 25 6 29.5 32.5 13 0 0 0 0 0
Other Investing Activities 0 0 0 0 0 0 0.3 0.7 0 0 0.0 (0.0) (0.2) 0 (0.0) (0.0) (0.7) 0.1 (0.3) 0.1 (0.3) 0.0 (0.1) 0
Investing Cash Flow 24.0 43.4 28.3 (92.1) 2.8 (47.7) 48.3 50.3 6.9 (37.0) 41.3 (37.8) 27.9 (12.7) (13.7) (13.5) (50.8) 30.9 12.2 (7.6) (77.2) (1.0) (0.4) 0
Financing Activities
Net Debt Issuance 0 0 (6) 0 0 6 0 0 0 6 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 0 145.5 6 0 0 0 0.4 (151.3) 19.3 0 0 0 0 (1.2) (0.7) (0.6) (1.3) (1.1) 0 0 0 35.0 0
Financing Cash Flow 0.4 0.4 0.6 144.8 0.2 6 0.0 38.5 0.0 157.3 0.2 0.3 0.1 0.1 184.1 (0.7) (0.6) (1.3) (1.1) (0.0) 268.1 2.3 35.0 10.0
Cash Position
Net Change in Cash (16.7) 1.1 (8.4) 17.6 (38.4) (90.6) 64.5 62.9 (38.6) 52.6 (2.4) (76.6) (12.9) (54.2) 139.7 (44.3) (71.6) (21.2) (2.1) (17.2) 184.5 (3.5) 37.0 8.6
Cash at Beginning 77.8 63.0 71.4 53.8 105.9 196.5 118.0 69.1 94.2 41.6 44.0 134.1 133.5 187.6 61.4 105.7 177.4 198.5 200.7 217.9 33.4 37.0 0 0
Cash at End 61.1 64.1 63.0 71.4 67.5 105.9 182.5 132.0 55.6 94.2 41.6 57.5 120.6 133.5 201.1 61.4 105.7 177.4 198.5 200.7 217.9 33.4 37.0 8.6
Free Cash Flow (41.1) (42.9) (37.5) (35.3) (43.0) (51.3) 14.5 (27.2) (47.4) (70.0) (45.7) (42.1) (42.8) (43.6) (35.5) (34.9) (25.0) (52.5) (13.6) (11.4) (7.3) (5.9) (2.8) (1.3)
Key Metrics 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2019 Q4
Income Statement
Revenue 1.2 0.9 0.8 1.2 1.1 1.5 2.2 0.2 0 0.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 1.2 (1) 0.8 (42.8) (0.7) 1.5 2.2 0.2 0 (0.7) 0 0 0 0 0 0 0 0 0 0 (1.2) (4.6) (1.3) 0
Operating Income (43.3) (50.7) (48.6) (54.0) (53.4) (52.4) (44.2) (54.2) (55.7) (48.3) (68.0) (51.5) (45.3) (40.0) (38.7) (31.7) (26.3) (19.9) (60.1) (10.4) (8.0) (6.0) (2.6) (2.2)
Net Income (42.1) (49.1) (46.1) (50.6) (52.6) (51.9) (42.3) (52.5) (55.3) (45.8) (65.6) (50.7) (42.4) (39.4) (39.3) (35.7) (29.3) (23.8) (62.9) (16.4) 0.6 (86.7) (2.6) (2.5)
EPS (Diluted) -0.24 -0.28 -0.26 -0.32 -0.41 -0.40 -0.36 -0.44 -0.46 -0.44 -0.67 -0.55 -0.47 -0.44 -0.42 -0.37 -0.37 -0.31 -0.72 -0.24 -0.04 -0.92 -0.04 -0.03
Balance Sheet
Cash & Equivalents 47.5 64.1 63.0 71.4 53.8 91.9 182.5 118.0 55.6 94.2 41.6 44.0 120.6 133.5 187.6 47.9 92.2 164.2 185.4 200.7
Total Assets 249.0 294.7 342.7 385.0 279.0 328.2 297.5 332.8 259.7 311.4 193.9 239.1 280.9 316.9 360.3 215.3 247.6 244.6 301.9 315.2
Total Debt 112.5 114.5 116.4 118.1 119.7 121.2 40.8 41.2 41.6 43.8 13.6 17.0 25.4 26.0 28.7 31.4 34.7 8.1 10.4 9.7
Stockholders' Equity 39.8 76.7 120.9 161.8 60.9 106.9 153.1 189.5 196.6 243.8 133.1 194.0 240.1 278.8 316.3 172.7 200.7 228.9 239.6 301.4
Cash Flow
Operating Cash Flow (41.0) (42.7) (37.3) (35.0) (41.4) (48.9) 16.2 (25.9) (45.5) (67.7) (43.9) (39.2) (40.8) (41.6) (30.7) (30.1) (20.2) (50.8) (13.2) (9.6) (6.4) (4.9) (2.5) (1.3)
Capital Expenditure (0.0) (0.2) (0.3) (0.2) (1.6) (2.4) (1.8) (1.3) (1.9) (2.3) (1.8) (2.9) (2.0) (2.0) (4.8) (4.8) (4.8) (1.7) (0.4) (1.8) (0.9) (1.0) (0.3) 0
Free Cash Flow (41.1) (42.9) (37.5) (35.3) (43.0) (51.3) 14.5 (27.2) (47.4) (70.0) (45.7) (42.1) (42.8) (43.6) (35.5) (34.9) (25.0) (52.5) (13.6) (11.4) (7.3) (5.9) (2.8) (1.3)